Physician profile
Bryan D Loh
NPI 1972753093
$5,590.00
in general payments reported to CMS, 2019-2025
21 companies · $380 in 2025
The $380 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $1,179 · 2021: $456 · 2022: $1,098 · 2023: $1,026 · 2024: $1,119 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,525.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,819.44 | 2020-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $403.38 | 2024-2025 | Gi Genius, Barrx, Interstim |
| Intercept Pharmaceuticals, INC. | $346.19 | 2019-2023 | Ocaliva |
| Aroa Biosurgery Incorporated | $330.80 | 2023-2024 | |
| Gilead Sciences, INC. | $323.16 | 2020-2022 | |
| Janssen Biotech, INC. | $270.58 | 2023 | Stelara |
| Janssen Scientific Affairs, LLC | $253.30 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $238.61 | 2021-2023 | Zeposia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $228.54 | 2021-2022 | |
| Abbvie INC. | $223.33 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $141.93 | 2023 | Rebyota |
| Innovation Technologies INC | $135.48 | 2024 | Irrisept |
| Nestle Healthcare Nutrition INC. | $123.41 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $123.34 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $118.99 | 2025 | Entyvio |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lucid Diagnostics INC. | $118.61 | 2022 | |
| Lilly USA, LLC | $118.45 | 2025 | |
| Apollo Endosurgery US INC | $111.07 | 2023 | Overstitch Endoscopic Suturing System |
| Davol INC. | $60.79 | 2024 | Phasix Mesh |
| Ethicon US, LLC | $56.47 | 2024 | Echelon; Endopath |
| Integra Lifesciences Corporation | $44.13 | 2023 | Integra, Integra Dermal Regeneration Template, Omnigraft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Loh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.